Skip to main content
OpenTrials

Clinical trial condition

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Explore clinical trials studying Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities. Study availability and eligibility vary by location and protocol.

113 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities trial results

Completed

A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)

NCT00045396

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +8 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions